CSat Investment Advisory’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-100
Closed -$17K 1004
2020
Q3
$17K Buy
100
+12
+14% +$2.04K ﹤0.01% 916
2020
Q2
$10K Buy
+88
New +$10K ﹤0.01% 1049